Verrica Pharmaceuticals Inc. (VRCA) Tops Q3 EPS by 21c

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) reported Q3 EPS of $0.13, $0.21 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $14.3 million versus the consensus estimate of $5.34 million.

For earnings history and earnings-related data on Verrica Pharmaceuticals Inc. (VRCA) click here.

You May Also Be Interested In

• Samsara Inc (IOT) call put ratio 4.5 calls to 1 put with a focus on September 4 weekly calls into quarter results
• Bernstein SocGen on DoorDash Inc. (DASH): 'What now for the stock?'
• Lands' End (LE) Tops Q2 EPS by 1c